Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats

Cell Transplantation

Volumn 14, Issue 6, 2005, Pages 411-421

  Aoki, Takeshi ^a   Hui, Hongxiang ^a   Umehara, Yutaka ^a   LiCalzi, Sergio ^a   Demetriou, Achilles A ^a   Rozga, Jacek ^a,b   Perfetti, Riccardo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Diabetes; Encapsulation; Insulin; Insulinoma cells; Pancreatic islets; Streptozotocin; Transplantation technique

Indexed keywords

GLUCOSE; INSULIN; STREPTOZOCIN; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DONOR; ENCAPSULATION; GENETIC ENGINEERING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOSUPPRESSIVE TREATMENT; INSULIN METABOLISM; INSULINOMA; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIMIAN VIRUS 40; SPLENECTOMY; STREPTOZOCIN DIABETES;

MUS MUSCULUS;

EID: 24944591004     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783982990     Document Type: Article

References (32)

1. Aoki, T.; Umehara, Y.; Ferraresso, C.; Sugiyama, N.; Middleton, Y.; Avital, I.; Inderbitzin, D.; Demetriou, A. A.; Rozga, J. Intrasplenic Transplantation of encapsulated cells: A novel approach to cell therapy. Cell Transplant. 11:553-561; 2002.
2. Benson, J. P.; Papas, K. K.; Constantinidis, I.; Sambanis, A. Towards the development of a bioartificial pancreas: Effects of poly-L-lysine on alginate beads with BTC3 cells. Cell Transplant. 6:395-402; 1997.
3. Bhargava, R.; Senior, P. A.; Ackerman, T. E.; Ryan, E. A.; Paty, B. W.; Lakey, J. R.; Shapiro, A. M. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 63:1311-1317; 2004.
4. Cai, Z. H.; Shi, Z.; Sherman, M.; Sun, A. M. Development and evaluation of a system of microencapsulation of primary rat hepatocytes. Hepatology 10:855-860; 1989.
5. Chae, S. Y.; Kim, Y. Y.; Kim, S. W.; Bae, Y. H. Prolonged glucose normalization of streptozotocin-induced diabetic mice by transplantation of rat islets coencapsulated with crosslinked hemoglobin. Transplantation 78: 392-397; 2004.
6. Clark, S. A.; Quaade, C.; Constandy, H.; Hansen, P.; Halban, P.; Ferber, S.; Newgard, C. B.; Normington, K. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 46:958-967; 1997.
7. deGroot, M.; Schuurs, T. A.; van Schilfgaarde, R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121:141-150; 2004.
8. Efrat, S. Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes. Ann. NY Acad. Sci. 875:286-293; 1999.
9. Fleischer, N.; Chen, C.; Surana, M.; Leiser, M.; Rossetti, L.; Pralong, W.; Efrat, S. Functional analysis of a conditionally transformed pancreatic beta-cell line. Diabetes 47: 1419-1425; 1998.
10. Hill, R. S.; Cruise, G. M.; Hager, S. R.; Lamberti, F. V.; Yu, X.; Garufis, C. L.; Yu, Y.; Mundwiler, K. E.; Cole, J. F.; Hubbell, J. A.; Hegre, O. D.; Scharp, D. W. Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann. NY Acad. Sci. 831:332-343; 1997.
11. Hui, H.; Yu, R.; Bousquet, C.; Perfetti, R. Transfection of pancreatic-derived beta-cells with a minigene encoding for human GLP-I restores glucose-dependent insulin synthesis and secretion. Endocrinology 143:3529-3539; 2002.
12. Hunter, S. K.; Kao, J. M.; Wang, Y.; Benda, J. A.; Rodgers, V. G. Promotion of neovascularization around hollow fiber bioartificial organs using biologically active substances. ASAIO J. 45:37-40; 1999.
13. Iwata, H.; Amemiya, H.; Matsuda, T.; Takano, H.; Hayashi, R.; Akutsu, T. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 38(Suppl. 1):224-225; 1989.
14. Kawakami, Y.; Inoue, K.; Hayashi, H.; Wang, W. J.; Setoyama, H.; Gu, Y. J.; Imamura, M.; Iwata, H.; Ikada, Y.; Nozawa, M.; Miyazaki, J. Subcutaneous xenotransplantation of hybrid artificial pancreas encapsulating pancreatic B cell line (MIN6): Functional and histological study. Cell Transplant. 6:541-545; 1997.
15. Kinoshita, N.; Echigo, Y.; Shinohara, S.; Gu, Y.; Miyazaki, J.; Inoue, K.; Imamura, M. Regulation of cell proliferation using tissue engineering in MIN6 cells. Cell Transplant. 10:473-477; 2001.
16. Kim, S. S.; Utsunomiya, H.; Koski, J. A.; Wu, B. M.; Cima, M. J.; Sohn, J.; Mukai, K.; Griffith, L. G.; Vacanti, J. P. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann. Surg. 228:8-13; 1998.
17. Lacy, P. E. Status of islet transplantation. Diabetes Rev. 1:76-92; 1993.
18. Lanza, R. P.; Sullivan, S. J.; Chick, W. L. Islet transplantation with immunoisolation. Diabetes 41:1503-1510; 1992.
19. Lim, F.; Sun, A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910; 1980.
20. Mamujee, S. N.; Zhou, D.; Wheeler, M. B.; Vacek, I.; Sun, A. M. Evaluation of immunoisolated insulin-secreting beta TC6-F7 cells as a bioartificial pancreas. Ann. Transplant. 2:27-32; 1997.
21. Morsiani, E.; Rozga, J.; Dellagiacoma, G.; Demetriou, A. A. Repeated intraportal injections of subtherapeutic islet cell isografts restore normoglycemia in streptozotocin-diabetic rats. Cell Transplant. 6:17-22; 1997.
22. Ohgawara, H.; Miyazaki, J.; Nakagawa, Y.; Sato, S.; Karibe, S.; Akaike, T. Xenoimplantation using a diffusion chamber with a B-cell line (MIN6) as a bioartificial endocrine pancreas (Bio-AEP). Cell Transplant. 5:871-73; 1996.
23. Ryan, E. A.; Lakey, J. R.; Rajotte, R. V.; Korbutt, G. S.; Kin, T.; Imes, S.; Rabinovitch, A.; Elliott, J. F.; Bigam, D.; Kneteman, N. M.; Warnock, G. L.; Larsen, I.; Shapiro, A. M. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50: 710-719; 2001.
24. Ryan, E. A.; Patty, B. W.; Senior, P. A.; Shapiro, A. M. Risks and side effects of islet transplantation. Curr. Diabetes Rep. 4:304-309; 2004.
25. Rosenthal, R. J.; Chen, S. C.; Hewitt, W.; Wang, C-C.; Eguchi, S.; Geller, S.; Phillips, E. H.; Demetriou, A. A.; Rozga, J. Techniques for intrasplenic hepatocytes transplantation in the large animal model. Surg. Endosc. 10: 1075-1079; 1996.
26. Scharp, D. W.; Mason, N. S.; Sparks, R. E. Islet immuno-isolation: The use of hybrid artificial organs to prevent islet tissue rejection. World J. Surg. 8:221-229; 1984.
27. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
28. Sigrist, S.; Mechine-Neuville, A.; Mandes, K.; Calenda, V.; Braun, S.; Legeay, G.; Belloca, J. P.; Pinget, M.; Kessler, L. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell Transplant. 12:627-635; 2003.
29. de la Tour, D.; Halvorsen, T.; Demeterco, C.; Tyrberg, B.; Itkin-Ansari, P.; Loy, M.; Yoo, S. J.; Hao, E.; Bossie, S.; Levine, F. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol. Endocrinol. 15: 476-483; 2001.
30. Trivedi, N.; Steil, G. M.; Colton, C. K.; Bonner-Weir, S.; Weir, G. C. Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. 8:115-124; 2000.
31. de Vos, P.; Hamel, A. F.; Tatarkiewicz, K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 45:159-173; 2002
32. Zhou, D.; Vacek, I.; Sun, A. M. Cryopreservation of microencapsulated porcine pancreatic islets: In vitro and in vivo studies. Transplantation 64:1112-1116; 1997.